Cellebrite Thomas Hogan Sells 103K Shares: Investor Outlook
Cellebrite's CEO moved a sizable stake, selling 103,000 shares for about $1.6 million. This article breaks down what ...
Learn how to choose a low-fee Dividend Aristocrats ETF and what fees to watch. This intro covers cost factors and quick tips for a cost-efficient selection.
24,603 articlesCellebrite's CEO moved a sizable stake, selling 103,000 shares for about $1.6 million. This article breaks down what ...
As UCB prepares to reveal Q2 results, investors should focus on revenue mix, pipeline progress, and margin resilience...
Bitcoin holds a tight $60,000 to $70,000 range as on-chain stress signals mount, signaling the bottom may not yet be ...
Amazon stock has cooled after a strong run, but bulls argue AI investments, AWS momentum, and ad growth could fuel a ...
Reading an earnings transcript can reveal how a company leverages international markets. This guide uses NPK Internat...
A moment on a beloved talent show has some fans puzzled and others energized. The question isn’t only about a verdict...
G-III Apparel faced a sharp slide after its latest earnings, signaling investor caution about licensing-heavy fashion...
Rocket Lab climbs on Neutron milestones as investors weigh SpaceX IPO chatter. The move underscores growing appetite ...
With earnings on the horizon and a bold pivot to AI infrastructure, investors face a tough call. This guide breaks do...
As InMode lays out its 2026 plan, investors want clarity on growth engines, margins, and execution. This article brea...
SoundHound AI is chasing a $140 billion total addressable market. This article breaks down what that TAM means for in...
Red Cat stock crashed today after the company announced a large share offering to raise capital. This piece breaks do...